Abstract
The concept, molecular self-assembly, especially considering molecule-molecule interaction as an informationprocessing phenomenon, have a profoundly novel effect on thoughts and efforts related to Medicine and Pharmacology. This new style of thinking is still too novice to be used solely and independently for explanation of disease mechanisms and appropriate treatment strategies. However it calls for a range of new researches based on new predictions about disease mechanisms (especially Autoimmune diseases, Endocrinopathies, and Neoplasms) and relevant treatment strategies (superstructural drugs).
Keywords: Self-assembly, Non-covalent interaction, Cell membrane, Autoimmunity, Anti-viral drugs, Sickle cell anemia
Current Pharmaceutical Analysis
Title: The Impact of Self-Assembly in Medicine and Pharmacology
Volume: 2 Issue: 1
Author(s): Mahnaz Derakhshan, Hamid R. Ansarian, Makoto Takafuji, Toshihiko Sakurai and Hirotaka Ihara
Affiliation:
Keywords: Self-assembly, Non-covalent interaction, Cell membrane, Autoimmunity, Anti-viral drugs, Sickle cell anemia
Abstract: The concept, molecular self-assembly, especially considering molecule-molecule interaction as an informationprocessing phenomenon, have a profoundly novel effect on thoughts and efforts related to Medicine and Pharmacology. This new style of thinking is still too novice to be used solely and independently for explanation of disease mechanisms and appropriate treatment strategies. However it calls for a range of new researches based on new predictions about disease mechanisms (especially Autoimmune diseases, Endocrinopathies, and Neoplasms) and relevant treatment strategies (superstructural drugs).
Export Options
About this article
Cite this article as:
Derakhshan Mahnaz, Ansarian R. Hamid, Takafuji Makoto, Sakurai Toshihiko and Ihara Hirotaka, The Impact of Self-Assembly in Medicine and Pharmacology, Current Pharmaceutical Analysis 2006; 2 (1) . https://dx.doi.org/10.2174/157341206775473990
DOI https://dx.doi.org/10.2174/157341206775473990 |
Print ISSN 1573-4129 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-676X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current and Future Therapies Targeting the Immune System in Multiple Sclerosis
Current Pharmaceutical Biotechnology The Role of Nitric Oxide in Autoimmune Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Case-control Association Study of Autoimmunity Associated Variants in PDCD1 and Juvenile Idiopathic Arthritis
Current Rheumatology Reviews Lipids at the Cross-road of Autoimmunity in Multiple Sclerosis
Current Medicinal Chemistry Pharmacokinetic and Toxicological Characteristics of Tripterigium Glycosides and Their Derivatives
Current Drug Metabolism History and Milestones of Mouse Models of Autoimmune Diseases
Current Pharmaceutical Design Histamine H4 Receptor: A Novel Therapeutic Target for Immune and Allergic Responses
Mini-Reviews in Medicinal Chemistry Bioinformatic Screening of Autoimmune Disease Genes and Protein Structure Prediction with FAMS for Drug Discovery
Protein & Peptide Letters Possible Role of DNA Methylation in the Induction of Systemic Lupus Erythematosus
Current Rheumatology Reviews Transglutaminases as Targets for Pharmacological Inhibition
Mini-Reviews in Medicinal Chemistry Biologics in Inflammatory Immune-mediated Systemic Diseases
Current Pharmaceutical Biotechnology The TOLL-like / Type-I Interferon Pathways as Emerging Therapeutic Targets for Autoimmune Diseases
Drug Design Reviews - Online (Discontinued) Systemic Sclerosis-Related Interstitial Lung Disease
Current Respiratory Medicine Reviews Deaza Analogs of Folic Acid as Antitumor Agents
Current Pharmaceutical Design Desirability Based Optimization of New Mesalazine Modified Release Formulations: Compression Coated Tablets and Mini Tablets in Capsules
Letters in Drug Design & Discovery Update on ICOS: A Possible Target for Turning-Off Autoimmunity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Endothelial Expression of MHC Class II Molecules in Autoimmune Disease
Current Pharmaceutical Design TNF, Cell Death and Inflammation
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Some Recent Insights into the Prothrombogenic Mechanisms of Antiphospholipid Antibodies
Current Medicinal Chemistry Gene Therapy Using IL-12 Family Members in Infection, Auto-Immunity, and Cancer
Current Gene Therapy